FDA Investigator

Charles Y Kuo

Latest inspection on record: Jhunan Township, Taiwan, April 2026 · records back to 2023

Human DrugsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 9 inspections across 9 sites are on record.
  • 18 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-27.

At a glance

Inspections

9

Sites

9

Observations

18

Career since

Feb 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Agricultural Technology Research Institute (ATRI)27 Apr 2026Human DrugsOn file
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.23 Sep 2025Human DrugsOn file
Akeso Biopharma Co., Ltd.4 Mar 2025Human DrugsOn file
Samsung Biologics Co., Ltd.30 Jul 2024Human DrugsOn file
CSL Behring GmbH30 Apr 2024Human DrugsOn file

Sites inspected

Akeso Biopharma Co., Ltd.Zhongshan, China1 insp.
Samsung Biologics Co., Ltd.Yeonsu District, Korea (the Republic of)1 insp.
CSL Behring GmbHMarburg, Germany1 insp.

Co-investigators

Investigators who share inspections with this person.

Zhong Li3 shared
Yun Wu2 shared
Wendy G Tan2 shared
You Zhuo1 shared
Yiwei Li1 shared

Full investigator report

Get the verbatim findings behind Charles Y Kuo's 18 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site